These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38463158)

  • 21. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel vaccination strategies and approaches against human tuberculosis.
    Méndez-Samperio P
    Scand J Immunol; 2019 Aug; 90(2):e12774. PubMed ID: 31054193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries.
    Ragonnet R; Trauer JM; Geard N; Scott N; McBryde ES
    BMC Med; 2019 Nov; 17(1):208. PubMed ID: 31752895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's Old and New in Tuberculosis Vaccines for Children.
    Cranmer LM; Cotton MF; Day CL; Nemes E
    J Pediatric Infect Dis Soc; 2022 Oct; 11(Supplement_3):S110-S116. PubMed ID: 36314550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A century of attempts to develop an effective tuberculosis vaccine: Why they failed?
    Soleimanpour S; Yaghoubi A; Sadat Seddighinia F; Rezaee SAR
    Int Immunopharmacol; 2022 Aug; 109():108791. PubMed ID: 35487086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.
    Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K
    BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of tuberculosis vaccines in clinical trials: Current status.
    Méndez-Samperio P
    Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine.
    Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N
    Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards new TB vaccines: What are the challenges?
    Dockrell HM
    Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCG vaccination strategies against tuberculosis: updates and perspectives.
    Qu M; Zhou X; Li H
    Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis vaccine: A journey from BCG to present.
    Fatima S; Kumari A; Das G; Dwivedi VP
    Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
    Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Deol A; Scarponi D; Iskauskas A; Bakker R; Quaife M; Malhotra S; Gebreselassie N; Zignol M; Hutubessy RCW; Giersing B; Jit M; Harris RC; Menzies NA; White RG
    Lancet Glob Health; 2023 Apr; 11(4):e546-e555. PubMed ID: 36925175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New vaccines against tuberculosis].
    Kaufmann SHE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):56-64. PubMed ID: 31784764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TB vaccines for the World.
    Glyn Hewinson R
    Tuberculosis (Edinb); 2005; 85(1-2):1-6. PubMed ID: 15687020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.